CRIS Current Research Information System

MORIGI, ALICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.647
AS - Asia 1.762
NA - Nord America 1.416
AF - Africa 94
SA - Sud America 74
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.998
Salva come PNG Salva come JPEG
Nazione #
NL - Olanda 2.020
US - Stati Uniti d'America 1.390
VN - Vietnam 625
DE - Germania 527
IT - Italia 448
SG - Singapore 416
CN - Cina 331
SE - Svezia 187
HK - Hong Kong 152
GB - Regno Unito 116
FR - Francia 75
RU - Federazione Russa 70
IN - India 58
BR - Brasile 51
IE - Irlanda 41
FI - Finlandia 40
UA - Ucraina 38
KR - Corea 30
JP - Giappone 29
TG - Togo 28
JO - Giordania 24
CI - Costa d'Avorio 23
NG - Nigeria 18
CA - Canada 16
ID - Indonesia 14
PL - Polonia 14
ZA - Sudafrica 14
AR - Argentina 13
BE - Belgio 13
TH - Thailandia 13
TR - Turchia 12
AT - Austria 11
ES - Italia 11
BD - Bangladesh 9
MX - Messico 8
PH - Filippine 7
TW - Taiwan 7
BG - Bulgaria 6
EE - Estonia 6
SA - Arabia Saudita 6
SC - Seychelles 6
IQ - Iraq 5
AU - Australia 4
CL - Cile 4
MY - Malesia 4
RO - Romania 4
RS - Serbia 4
UZ - Uzbekistan 4
DK - Danimarca 3
LT - Lituania 3
PT - Portogallo 3
EC - Ecuador 2
IR - Iran 2
KE - Kenya 2
MK - Macedonia 2
OM - Oman 2
PK - Pakistan 2
PS - Palestinian Territory 2
QA - Qatar 2
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
IL - Israele 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
NO - Norvegia 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
Totale 6.998
Salva come PNG Salva come JPEG
Città #
Eygelshoven 1.286
Kerkrade 666
Frankfurt am Main 355
Singapore 303
Ashburn 197
Chandler 141
Hong Kong 140
Ho Chi Minh City 138
Santa Clara 117
Fairfield 95
Dong Ket 93
Hanoi 93
Southend 87
San Jose 72
Bologna 68
Milan 53
Beijing 45
Hefei 45
Princeton 44
Rome 42
Dublin 41
Houston 41
Los Angeles 37
Seattle 37
Boardman 34
Helsinki 33
Kyiv 31
Falkenstein 30
Berlin 29
Lomé 28
Lauterbourg 27
Wilmington 27
Da Nang 26
Woodbridge 26
Amman 24
New York 24
Seoul 24
Abidjan 23
Cambridge 23
Ann Arbor 22
Tokyo 21
Bremen 16
Abeokuta 15
Haiphong 14
Redmond 13
Secaucus 13
Brussels 12
Buffalo 11
Council Bluffs 11
Düsseldorf 11
Turin 11
Warsaw 11
Catania 10
Chicago 10
Nanjing 10
Westminster 10
Columbus 9
Guangzhou 9
Jinan 9
Shenyang 9
São Paulo 9
Florence 8
Istanbul 8
Jakarta 8
Olalla 8
Toronto 8
Bangkok 7
Dallas 7
Des Moines 7
Hưng Yên 7
Lappeenranta 7
London 7
Nuremberg 7
San Diego 7
Verona 7
Zhengzhou 7
Amsterdam 6
Bengaluru 6
Bến Tre 6
Jiaxing 6
Modena 6
Orem 6
Quận Bình Thạnh 6
Vienna 6
Brooklyn 5
Changsha 5
Hangzhou 5
Hyderabad 5
Hải Dương 5
Jeddah 5
Nha Trang 5
Ottawa 5
Padova 5
Parma 5
Quận Một 5
Redwood City 5
Reggio Emilia 5
Saint Petersburg 5
Thái Nguyên 5
Baghdad 4
Totale 5.148
Salva come PNG Salva come JPEG
Nome #
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years 2.841
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience 427
Design of New Personalized Therapeutic Approaches for Diffuse Large B-Cell Lymphoma through Gut Microbiome Profiling 232
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study 223
The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience 222
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients 205
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone Lymphoma 199
Long-term responders after Brentuximab vedotin: Single-center experience on relapsed and refractory hodgkin lymphoma and anaplastic large cell lymphoma patients 199
The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients 194
PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series 188
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies 173
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma 169
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia 164
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma 163
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients 163
Granulomatous tattoo reaction in a nivolumab-treated patient 157
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 152
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience 147
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience 142
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series 123
Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma 120
Long-term efficacy and safety of ibrutinib in the treatment of CLL patients: A real life experience 120
Spontaneous remission of follicular lymphoma 105
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 103
Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation 89
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report 77
Totale 7.097
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021174 0 0 0 0 0 0 0 0 0 9 16 149
2021/2022480 81 11 16 43 30 18 3 36 13 57 106 66
2022/2023645 46 100 49 85 54 43 14 61 99 16 40 38
2023/2024277 19 40 27 35 27 29 12 19 9 26 10 24
2024/20251.126 69 104 83 74 169 80 104 54 27 108 52 202
2025/20263.941 159 194 114 131 163 1.398 1.230 45 400 107 0 0
Totale 7.097